Technology
Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation ‘Agnostic Diagnostics’ for Respiratory Viruses at the Point of Care
Published
2 years agoon
By
International consortium to develop rapid metagenomic NGS solutions that can identify known and novel respiratory pathogens, reduce time-to-diagnosis, and enhance hospital decision-making and public health preparedness
BOSTON, Feb. 20, 2025 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a collaboration with the European Health and Digital Executive Agency (HaDEA) as contracting authority under a joint tender of up to €24 million. The funding is made available through the EU4Health programme, linked to the key priorities of the Health Emergency Preparedness and Response Authority (HERA) of the European Commission.
The partnership, RApid Next Generation Sequencing for Effective Medical Response (RANGER), aims to develop a rapid, point-of-care metagenomic next-generation sequencing (mNGS) solution that enables hospitals and other healthcare facilities to achieve rapid turnaround diagnostics for respiratory viruses – capabilities that move us closer to a “Star Trek tricorder”- style tool for biosecurity and public health. Under this award, Ginkgo and its consortium partners are eligible to receive up to €24 million over the next 4 years.
RANGER seeks to transform the diagnostic landscape, enabling clinicians to diagnose complex respiratory conditions quickly and efficiently at the bedside with a device that allows for fully automated push-button sample preparation. With 6-hour turnaround time, hospitals could gain critical flexibility and optionality, allowing them to rapidly triage patients and reduce the burden of prolonged isolation, empirical therapies, and costly inpatient stays.
“Agnostic diagnostics” means the device wouldn’t just look for a handful of known targets; it could sequence and identify virtually any respiratory pathogen, including emergent or engineered pathogens. This could significantly enhance pandemic preparedness. The program also offers the European Commission the option to procure 200 devices at preferred pricing, which could enable widespread and scalable deployment across EU/EEA healthcare systems.
The program is designed to be delivered in three phases. In the first phase, Ginkgo will work with a consortium of technology partners – Jumpcode, TGen, Bugseq, and Planet Innovation – to bring together existing technologies at different stages of technology readiness in one benchtop device. That device will then be taken through clinical trials in hospital settings in the EU in partnership with KU Leuven (Belgium), Karolinska University Hospital (Sweden), and Tartu University Hospital (Estonia) during the second phase of the program. Once clinical trials have been satisfactorily completed, Ginkgo will collaborate with medical device regulatory specialists at the QbD Group to secure EU certification and validation for certain analytes and sample types before bringing the RANGER device to market.
This collaboration aligns with HERA’s mission to strengthen Europe’s ability to prevent, detect, and rapidly respond to cross-border health emergencies, as it seeks to expand the availability of and access to key medical countermeasures. By supporting the development of near-patient sequencing capabilities, HERA and HaDEA aim to reduce diagnostic delays, enhance hospital triage and infection control, and provide a powerful early-warning tool against emerging pathogens. “Diagnostics as decision making tools are a key component of our toolbox to rapidly respond to health emergencies. The ability to quickly identify even previously unknown pathogens will be a critical step in reinforcing the EU’s collective health resilience,” said Laurent Muschel, Acting Director-General of HERA.
“HaDEA is committed to fostering innovative solutions that can strengthen Europe’s capacity to prevent, detect, and respond to biological threats,” said Marina Zanchi – Director of HADEA. “This project represents a leap forward in leveraging next-generation sequencing at the bedside, and we believe the collaborative approach taken by Ginkgo and its partners will greatly accelerate the path toward safer, more prepared healthcare systems across the region.”
“This collaboration with HaDEA embodies our mission at Ginkgo Biosecurity to arm global healthcare systems with cutting-edge capabilities,” said Matt McKnight, General Manager of Ginkgo Biosecurity. “Instead of waiting days to confirm a diagnosis, we want doctors to be able to run a sample through this machine and get results in about 6 hours. Ultimately, this means faster triage, better patient outcomes, and a more resilient frontline response to both seasonal viruses and future pandemics.”
“We’re moving toward a diagnostic model that’s as easy and quick as scanning a patient’s sample right on the spot,” added Dr. Nita Madhav, Head of Epidemiology & Global Risk Analytics at Ginkgo Bioworks. “The European Commission’s decision to fund this effort not only accelerates access to innovative medical countermeasures but also enables a step-change in how we detect and respond to novel respiratory pathogens. Our integrated approach—incorporating metagenomic sequencing, computational design, and predictive analytics—will help clinicians and public health leaders stay ahead of the curve.”
“We’re excited to be part of the RANGER consortium, which in partnership with Jumpcode’s CRISPR-based technology, represents a significant advancement in diagnostic capabilities. By enabling faster and more comprehensive pathogen detection through our Cipher system, we’re taking an important step forward in improving clinical diagnostics and enhancing pandemic preparedness,” said Mike Salter, CEO of Jumpcode Genomics.
“TGen is focused on translating genomic findings to the clinic and the RANGER project and the outstanding collaborators involved are excellent vehicles for setting precedents in the translational research space” says Dr. Nicholas J. Schork, Professor at TGen whose lab published findings with Jumpcode on the initial version of the system to be developed and evaluated in the proposed research.
“BugSeq is thrilled to partner with RANGER consortium members to deploy our clinically-tailored bioinformatics platform to advance the use of rapid metagenomic sequencing for infectious disease diagnostics,” said Sam Chorlton, CEO of BugSeq. “This collaborative effort to develop a seamless, end-to-end solution marks a significant step forward in accelerating the adoption of agnostic diagnostics and strengthening our ability to respond swiftly to public health emergencies.”
“Planet Innovation is proud to be a part of the RANGER consortium, and will leverage its large product development and manufacturing capabilities in developing the highly innovative Cipher system. Planet Innovation has extensive experience in developing world-class platforms and we look forward to working alongside Jumpcode Genomics and all the consortium members in delivering a diagnostic solution that provides better patient outcomes, and a more resilient frontline response to both seasonal viruses and future pandemics,” said Stuart Elliott, CEO of Planet Innovation.
To learn more about how you can benefit from Ginkgo Biosecurity, please visit our website at https://biosecurity.ginkgo.bio.
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.
GINKGO BIOWORKS INVESTOR CONTACT:
investors@ginkgobioworks.com
GINKGO BIOWORKS MEDIA CONTACT:
press@ginkgobioworks.com
Forward-Looking Statements of Ginkgo Bioworks
This press release contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the capabilities and potential success of the partnership and Ginkgo’s cell programming platform. These forward-looking statements generally are identified by the words “believe,” “can,” “project,” “potential,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) volatility in the price of Ginkgo’s securities due to a variety of factors, including changes in the competitive and highly regulated industries in which Ginkgo operates and plans to operate, variations in performance across competitors, and changes in laws and regulations affecting Ginkgo’s business, (ii) the ability to implement business plans, forecasts, and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry, including due to advancements in technology, emerging competition and evolution in industry demands, standards and regulations, (vi) the outcome of any pending or potential legal proceedings against Ginkgo, (vii) our ability to realize the expected benefits from and the success of our Foundry platform programs, (viii) our ability to successfully develop engineered cells, bioprocesses, data packages or other deliverables, and (ix) the product development or commercialization success of our customers. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of Ginkgo’s annual report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 29, 2024, Ginkgo’s most recent quarterly report on Form 10-Q, and other documents filed by Ginkgo from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Ginkgo assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Ginkgo does not give any assurance that it will achieve its expectations.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-partners-with-hadea-in-up-to-24-million-consortium-project-to-deliver-next-generation-agnostic-diagnostics-for-respiratory-viruses-at-the-point-of-care-302381350.html
SOURCE Ginkgo Bioworks
You may like
Technology
Oracle Investor Day 2026: Accelerating Value Creation
Published
23 minutes agoon
October 28, 2026By
Set long-term outlook for FY30 of $225 billion+ in total revenue, representing more than 35% CAGR from FY26, non-GAAP operating margin of 40%+ and non-GAAP EPS $21+.Defined timeline to positive free cash flow during the second half of FY28 and set free cash flow target of $30 billion+ for FY29.Committed to limiting additional capital raises through FY30 to $20 billion, excluding refinancing of existing debt, split between $10 billion in equity and $10 billion in gross debt.Confirmed that growth will be self-funded beginning in FY29 and net debt to adjusted EBITDA will be below 3.5 times in FY29.1
AUSTIN, Texas, Oct. 28, 2026 /PRNewswire/ — Oracle Corporation (NYSE: ORCL) today hosted an Investor Day in Las Vegas, NV. At the event co-CEO Clay Magouryk, co-CEO Mike Sicilia and CFO Hilary Maxson presented and responded to questions about the company’s strategy and updated medium-term financial guidance.
At its Investor Day, Oracle described how its unique portfolio positioning across cloud infrastructure, database and applications is expected to drive total revenue growth of more than 35% CAGR from FY26 through FY30, reaching total revenue of $225 billion or more in FY30. It also outlined its expectations for strong profitability and free cash flow generation from each of its three business models. Following a period of peak capex in FY27-FY28, capital expenditures are expected to step-down in FY29, supporting positive free cash flow of at least $30 billion in FY29.
Oracle committed to limiting additional funding to be raised in the capital markets for its FY27-FY30 investment cycle to $20 billion, currently expected to be $10 billion in equity and $10 billion in gross debt. This incremental funding requirement excludes refinancing of existing debt. This is in addition to the $20 billion at-the-market equity raise completed in the first quarter of fiscal 2027. Vendor financing, customer-provided hardware and customer prepayments are expected to reduce upfront cash requirements through the transition to positive free cash flow.
Oracle reaffirmed its fiscal 2027 outlook for total revenue of at least $90 billion and non-GAAP earnings per share of $8.10. The company’s capital allocation priorities remain maintaining investment-grade credit ratings, paying a dividend and funding growth opportunities.
The Investor Day presentations and webcast replay will be available on the Oracle Investor Day website.
1. Net debt includes borrowings, vendor financing, and operating and finance lease liabilities, less cash and marketable securities. Adjusted EBITDA is based on Oracle’s reported non-GAAP results, with depreciation and operating lease expense added back.
About Oracle
Oracle provides cloud applications and infrastructure for enterprises worldwide. For more information about Oracle (NYSE: ORCL), visit www.oracle.com.
Non GAAP Financial Measures
To supplement our financial results presented on a GAAP basis, we use non-GAAP measures, which exclude certain significant expenses including stock-based compensation, expenses related to acquisitions, restructuring and certain other operating expenses, that we believe are helpful in understanding our past financial performance and our future results. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.
Safe Harbor Statement
Statements in this press release relating to Oracle’s future plans, expectations, beliefs, intentions and prospects, including statements regarding future revenues and revenue growth, non-GAAP operating margin and earnings per share; the timing and amount of positive free cash flow; expected capital expenditures; future funding needs and financing strategy, including Oracle’s commitment to limit additional capital raises; the expected effects of vendor financing, customer-provided hardware and customer prepayments on upfront cash requirements; the timing of self-funded growth; future net debt to adjusted EBITDA; and capital allocation priorities, including maintaining investment-grade credit ratings, paying dividends and funding growth opportunities, are “forward-looking statements” and are subject to material risks and uncertainties. Forward-looking statements may be identified by words such as “expect,” “anticipate,” “plan,” “believe,” “intend,” “target,” “will,” and “committed,” and similar expressions, although not all forward-looking statements contain these words. Risks and uncertainties that could affect our current expectations and our actual results, include, among others: our ability to develop new products and services, integrate acquired products and services and enhance our existing products and services, including our AI products; our AI products not operating as anticipated; our ability to successfully execute our Oracle Cloud strategy; our ability to anticipate, plan for, secure and manage datacenter capacity; our management of complex cloud and hardware offerings, including the sourcing of technologies and technology components such as graphic processing units; significant coding, manufacturing or configuration errors in our offerings; risks associated with acquisitions, joint ventures and strategic alliances; business volatility and risks associated with government contracting; economic, political and market conditions, including tariffs and trade wars; information technology system failures, privacy and data security concerns; cybersecurity breaches; disruptions from our period workforce restructurings; unfavorable legal proceedings, government investigations, and complex and changing laws and regulations, including healthcare regulations. A detailed discussion of these factors and other risks that affect our business is contained in our SEC filings, including our most recent reports on Form 10-K and Form 10-Q, particularly under the heading “Risk Factors.” Copies of these filings are available online from the SEC or by contacting Oracle’s Investor Relations Department at (650) 506-4073 or by clicking on SEC Filings on the Oracle Investor Relations website at www.oracle.com/investor/. All information set forth in this press release is current as of October 28, 2026. Oracle undertakes no duty to update any statement in light of new information or future events.
View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-investor-day-2026-accelerating-value-creation-302922564.html
SOURCE Oracle
Technology
Chip Earnings Power Averages Higher as Nasdaq Volatility Cools Midweek
Published
23 minutes agoon
October 28, 2026By
VANCOUVER, BC, Oct. 28, 2026 /PRNewswire/ — Stock Preachers News Commentary – Major U.S. indices pushed higher midweek, with the S&P 500 up 1.51% and the Nasdaq Composite up 1.98% over the week’s three sessions, as semiconductor and tech earnings drove gains while mega-cap names digested mixed results. The Dow gained 0.62% for the week to 52,536.29. Nasdaq volatility, measured by the VXN, fell 3.51 points for the week to 24.79, while WTI crude jumped 3.47% on the day to $103.37 a barrel. Active Companies from around the markets with current developments this week include: Texas Instruments Incorporated (Nasdaq: TXN), Meta Platforms, Inc. (Nasdaq: META), IBM (NYSE: IBM), Broadcom Inc. (NYSE: BAC) (NYSE: BX) (NYSE: C) (NYSE: MS), and Lockheed Martin (NYSE: LMT).
The S&P 500 closed at 7,739.13, up 0.21% on the day and 1.51% for the week, trading between a weekly low of 7,639.70 and a high of 7,742.75. Its RSI14 sits at 52.6, with resistance at 7,770.40 and support at 7,734.10, the 20-day SMA. The index is up 13.05% year to date.
The Nasdaq Composite slipped 0.03% on the day to 26,468.60 but remains up 1.98% for the week after touching a high of 26,582.01. RSI14 reads 47.5, with resistance at the 50-day EMA near 26,541.13 and support at the 10-day EMA around 26,439.69. The Dow added 158.72 points, or 0.30%, to 52,536.29, within range of resistance near 52,691.31.
The VIX eased to 17.31, down 1.08 points for the week, while the VXN dropped to 24.79 from a weekly high of 28.30, signaling calmer tech sentiment. The 10-year Treasury yield rose 4 basis points on the day and the week to 5.03%. Natural gas surged 13.87% on the day and 18.02% for the week, while gold slipped 0.59% to $4,050.70 an ounce.
The full report also walks through the index level ladder, sector standouts, and sentiment heading into the final sessions of the week.
CONTINUED… Read this and more news for Texas Instruments Incorporated (Nasdaq: TXN), Meta Platforms, Inc. (Nasdaq: META), IBM (NYSE: IBM), Broadcom Inc. (NYSE: BAC) (NYSE: BX) (NYSE: C) (NYSE: MS), and Lockheed Martin (NYSE: LMT) at: https://stockpreachers.com/articles/chipmakers-run-the-table-while-mega-caps-catch-their-breath/
In other industry developments and happenings in the market this week include:
Texas Instruments Incorporated (Nasdaq: TXN) Texas Instruments reported third quarter revenue of $6.06 billion, net income of $2.43 billion and earnings per share of $2.62, with revenue up 28% from the same quarter a year ago and operating profit up 73% to $2.87 billion.
Chairman, president and CEO Haviv Ilan said, “Revenue increased 11% sequentially and 28% from the same quarter a year ago with continued broad growth in industrial, automotive and data center.” He added that trailing 12-month cash flow from operations reached $9.9 billion and free cash flow was $8.4 billion, with $5.8 billion returned to owners over the period.
TI guided fourth quarter revenue in a range of $5.80 billion to $6.30 billion and earnings per share between $2.45 and $2.79. Read the release.
Meta Platforms, Inc. (Nasdaq: META) Meta Platforms reported third quarter revenue of $64.60 billion, up 26% year-over-year, with net income of $9.86 billion, up 264%, and diluted earnings per share of $3.83, up 265% from a year ago.
The quarter included a $9.89 billion charge tied to an agreement with 52 attorneys general on teen mental health and social media litigation, which carries payments of up to approximately $18.59 billion. Excluding the charge, income from operations would have been $22.88 billion and diluted EPS would have been $7.40.
Founder and CEO Mark Zuckerberg said, “We hit major milestones this quarter toward delivering personal superintelligence for everyone… Our investments are paying off, the core business is strong, and we’re seeing velocity across the board.” The company guided fourth quarter revenue of $73 billion to $76 billion and narrowed 2026 capital expenditure guidance to $135 billion to $145 billion. Read the release.
IBM (NYSE: IBM) IBM reported third-quarter revenue of $17.1 billion, up 5%, with Software revenue up 8% and Infrastructure revenue up 4%. Net income reached $2.2 billion with diluted earnings per share of $2.31, up 26% year-over-year.
Chairman, president and CEO Arvind Krishna said, “Disciplined execution throughout the quarter drove accelerated revenue growth and strong free cash flow,” adding that the company now expects free cash flow to increase by more than $1 billion year-over-year for the full year.
CFO James Kavanaugh said the results reflect “strong operational execution” that led to “accelerated growth and solid operating pre-tax margin expansion in the quarter.” IBM generated $4.0 billion in net cash from operating activities in the quarter and returned $1.6 billion to shareholders in dividends. Read the release.
Broadcom Inc. (NYSE: BAC) (NYSE: BX) (NYSE: C) (NYSE: MS) Bank of America, Blackstone, Citi and Morgan Stanley announced a $63 billion financing structure to enable AI compute capacity leveraging Broadcom’s technology for Anthropic, with deliveries expected starting in calendar 2027.
The deal is executed through a special purpose vehicle supporting the purchase of Broadcom XPU AI accelerators and networking solutions to be leased to Anthropic, with Broadcom providing residual value support equivalent to the first lien portion of financing.
Hock Tan, President and CEO of Broadcom, said, “Today’s transaction underscores the power of our advanced technology and our strong conviction in the AI ecosystem… This validates that there is capital available to finance such growth and that Broadcom is uniquely positioned to enable it.” Read the release.
Lockheed Martin (NYSE: LMT) Lockheed Martin was awarded a $694 million contract from the U.S. Air Force for production of the Air-Launched Rapid Response Weapon, a hypersonic missile integrated on the B-52 capable of traveling at speeds greater than Mach 5.
The company broke ground on a Building P-20 expansion in Troy, Alabama, adding 47,000 square feet of production space that will triple the facility’s current capacity and add jobs over the next four years, building on almost 4,000 existing Lockheed Martin employees in the state.
Tim Cahill, president, Lockheed Martin Missiles and Fire Control, said, “The ARRW production contract award showcases Lockheed Martin’s ability to develop and begin production on cutting-edge systems at unprecedented speed and scale.” Read the release.
Contact Information:
Media Contact: info@stockpreachers.com
DISCLAIMER: Nothing in this article should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a market commentary and is not a paid advertisement. This article is being distributed by Stock Preachers, which is wholly owned and operated by Market Equities Limited (“MEL”), a company incorporated under the laws of Ireland. This is an independent market commentary published on a non-paid basis. MEL has not been paid any fee by any company mentioned in this article for its production or distribution, and MEL has no advertising or digital media agreement with any company mentioned in this article. The companies mentioned have not reviewed or approved this article. Market Equities and its owners, operators, directors, and affiliates may, from time to time, hold positions in securities mentioned in this article or in the broad-market index funds that track them, and reserve the right to buy, sell, or hold such securities at any time without further notice. Information in this article was obtained from sources believed to be reliable, including company news releases and public market data, but its accuracy cannot be guaranteed. Market data is as of the time stated and may be delayed. Portions of this commentary were produced with the assistance of automated tools from that data and reviewed against it. Investing in securities involves risk, including the possible loss of some or all of your investment. Technical analysis describes past price and volume behavior and does not predict future results; support and resistance levels can fail at any time. References to the companies named in this article are provided solely as market and sector context and as summaries of each company’s own public news releases. No partnership, affiliation, or endorsement is implied, and nothing in this article is a recommendation to buy, sell, or hold any security. Quotations attributed to company executives are reproduced from those companies’ own news releases. Forward-Looking Statements: This article may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements made by the companies mentioned in their own news releases. Such statements involve risks and uncertainties, and actual results may differ materially. Readers should review each company’s filings with the SEC and applicable Canadian securities regulators. Eagle Eye is an investor signal-intelligence platform affiliated with the publisher of this article. Eagle Eye is not a broker-dealer, and nothing it provides is investment advice. Data may be delayed. Always do your own research.
View original content to download multimedia:https://www.prnewswire.com/news-releases/chip-earnings-power-averages-higher-as-nasdaq-volatility-cools-midweek-302922565.html
SOURCE Stock Preachers
Technology
Fortune Media and Great Place To Work Name Roth Staffing Companies to 2026 Best Workplaces for Women List, Ranking No. 2
Published
23 minutes agoon
October 28, 2026By
ORANGE, Calif., Oct. 28, 2026 /PRNewswire/ — Great Place To Work® and Fortune magazine have selected Roth Staffing Companies as one of the 2026 Fortune Best Workplaces for Women™. This is Roth Staffing’s 11th time being named to this prestigious list, this year coming in at No. 2. Earning a spot means that Roth Staffing is one of the best companies to work for in the country.
To determine the Best Workplaces for Women, Great Place To Work analyzed the survey responses of over 640,000 women who work for Great Place To Work Certified™ companies that were eligible for the list. To be considered, a company must employ at least 50 women, have at least 20% of non-executive managers who are women, and have at least one female C-suite executive.
“Being recognized as one of the Fortune Best Workplaces for Women for the 11th time is an incredible honor,” said Pam Sexauer, President of Roth Staffing Companies. “At Roth Staffing, we believe creating a workplace where women feel valued, supported, and empowered to grow is essential to building a thriving organization. This recognition reflects the culture our coworkers create every day, rooted in respect, belonging, opportunity, and caring for one another. I am grateful to our teams for making Roth Staffing a place where people can do meaningful work and build rewarding careers.”
The Best Workplaces for Women list is highly competitive. Survey responses reflect a comprehensive picture of the workplace experience. Honorees were selected based on their ability to offer consistently positive outcomes for women regardless of job role, work status, or any other demographic identifier.
“Companies that create great experiences for women are companies that create better experiences for every employee,” says Michael C. Bush, CEO of Great Place To Work. “When a company can show that anyone can build a career and do their life’s work, that company is more resilient. These companies are built for the future because they invest in the future of their people.”
“Congratulations to the companies recognized as Fortune Best Workplaces for Women,” says Fortune Executive Editor Ashley Lutz. “This recognition is especially meaningful because it reflects the voices and experiences of women themselves—and highlights the companies creating environments where they can grow, contribute, and do their best work.”
About Roth Staffing Companies
Roth Staffing Companies is one of the largest privately held staffing firms in the United States, operating from more than 100 locations across 20 states and the District of Columbia. Roth Staffing consists of five specialized business lines: Ultimate Staffing Services for administrative and office positions, Ledgent Finance & Accounting, Ledgent Technology, Adams and Martin Group for legal staffing, and About Talent for workforce solutions.
About the Fortune Best Workplaces for Women
Great Place To Work selected the 2026 Fortune Best Workplaces for Women List by analyzing the survey responses of over 640,000 women who work for Great Place To Work Certified companies that also meet the criteria for this list. To be eligible, a company must employ at least 50 women, have at least 20% of non-executive managers who are women, and have at least one female C-suite executive. Company rankings are derived from 60 employee experience questions within the Great Place To Work Trust Index™ Survey. Read the full methodology.
About Great Place To Work
As the global authority on workplace culture, Great Place To Work, a UKG company, brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Its proprietary platform and Great Place To Work Model help companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified and receiving recognition on a coveted Best Workplaces list.
Follow Great Place To Work on LinkedIn, X, and Instagram, and sign up for the Great Place To Work LinkedIn newsletter, Culture Edge, to get the latest research on what drives business success.
About Fortune Media
Fortune is a global multi-platform media company built on a legacy of trusted, award-winning reporting and information for those who want to make business better. Independently owned, Fortune tells the stories of the world’s biggest companies and their leaders as well as a new generation of innovators who are moving business forward. Digitally and in print, Fortune measures corporate performance through rigorous benchmarks and holds companies accountable in regions around the world. Its iconic rankings include Fortune 500, Fortune Global 500, Most Powerful Women, and World’s Most Admired Companies. Fortune builds world-class communities by convening industry thought leaders for exclusive summits and conferences, including the Fortune Global Forum, Fortune Brainstorm Tech, and Fortune Most Powerful Women. For more information, visit fortune.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/fortune-media-and-great-place-to-work-name-roth-staffing-companies-to-2026-best-workplaces-for-women-list-ranking-no-2-302922494.html
SOURCE Roth Staffing Companies
Oracle Investor Day 2026: Accelerating Value Creation
Chip Earnings Power Averages Higher as Nasdaq Volatility Cools Midweek
Fortune Media and Great Place To Work Name Roth Staffing Companies to 2026 Best Workplaces for Women List, Ranking No. 2
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market5 days agoIRS plans lower tax disclosure penalties, including for crypto: Forbes
-
Coin Market5 days agoWells Fargo and five others object to OKX-ICE tokenized stock listings: Report
-
Technology5 days agoModern Wealth Law Founder John Wong Recognized for Over 10 Years as a State Bar of California Certified Specialist
-
Technology5 days agoChelsea FC announces multi-year sleeve partnership with Sokin, the business payments and FX platform
-
Technology5 days agoSTEPHEN A. SMITH ADDRESSES WHITE HOUSE DINNER ATTENDANCE, REAFFIRMS COMMITMENT TO HBCUs AND PROTECTING CORPORATE INVESTMENT IN BLACK EDUCATION
-
Technology4 days agoST Engineering iDirect and MBSat Partner to Build Next-Generation Sovereign Connectivity Services Across Oman and the Middle East
-
Technology4 days agoST Engineering iDirect and MBSat Partner to Build Next-Generation Sovereign Connectivity Services Across Oman and the Middle East
-
Technology3 days agoBeyond GRC: DigitalXForce Pioneers AI-Powered Risk Operations with Global X-ROC™ Rollout
